Evaluation of trisomy 21 screening thresholds is crucial for improving prenatal care and minimizing patient anxiety. For years, clinicians have relied on a fixed 1:300 cut-off for first-trimester combined screening (CST). However, recent evidence suggests this standard approach yields high false-positive rates (FPR), particularly as maternal age increases. Consequently, older individuals often face unnecessary stress and invasive diagnostic procedures. A retrospective study of 13,668 pregnancies highlights these significant limitations. Specifically, the standard cut-off resulted in an FPR of 38.5% for women aged 40 and older.

Optimizing Results with Trisomy 21 Screening Thresholds

Researchers evaluated alternative strategies to mitigate age-related inflation of false results. In contrast to fixed models, an age-dependent strategy maintains a near-constant FPR of 5.4% across all age groups. Therefore, this approach offers a more balanced diagnostic performance. Moreover, it achieved a detection rate of 81.3% for trisomy 21. While a global 5% FPR threshold significantly reduces false positives, it also lowers the detection rate too much. Consequently, age-specific calibration provides the highest diagnostic efficiency. Additionally, practitioners must remember that binary classifications based on single risk estimates have inherent limitations. Ultimately, transitioning to individualized thresholds could refine screening accuracy for diverse patient populations.

Frequently Asked Questions

Why is the standard 1:300 threshold problematic for older women?

The standard threshold causes a sharp increase in false-positive results as maternal age rises, reaching nearly 39% in women over 40 years of age.

How does an age-dependent strategy benefit prenatal screening?

It keeps the false-positive rate stable at around 5% regardless of age. This reduces unnecessary invasive testing while maintaining high detection accuracy for trisomy 21.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Szenejko PI et al. Limitations of fixed risk thresholds in first-trimester combined screening for trisomy 21. Ginekol Pol. 2026 Jun 09. doi: 10.5603/gpl.110345. PMID: 42261731.


2. International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). ISUOG Practice Guidelines: first-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2023.


3. Fetal Medicine Foundation. Screening for chromosomal abnormalities: First-trimester combined test standards. 2024.